What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We've spent the last ...

WeightWatchers said Friday that its CEO Sima Sistani, who shifted the weight loss giant’s strategy to prescribing obesity ...

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some ...

Johnson & Johnson and Legend Biotech's CAR-T cell therapy Carvykti reduced the risk of death by 45% compared to standard of ...

Travere Therapeutics said there is a “voluntary pause” in recruitment to its Phase 3 study in a rare, inherited disorder due ...

Cassava Sciences and two of its former executives have reached a resolution with the SEC over charges for “misleading” ...

While the worst of the funding slump for digital health startups since the lofty highs of the pandemic seems to be drawing to ...

The biggest drug driving Sanofi’s and Regeneron’s businesses is about to get a bit bigger. On Friday, the FDA approved ...

Lavigne Total raised More than $1 billion in committed capital Headquarters South San Francisco, CA David Baker’s Seattle ...

Amgen released data from two pivotal trials on Tuesday that showed its experimental drug rocatinlimab succeeded in a Phase 3 ...

Johnson & Johnson is winding down its pharma division's cardiovascular and metabolic unit, Endpoints News has learned. The ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...